In current clinical practice, cancer tissue biopsies are used to analyze genetic mutations. However, this approach has limitation such as side effects, costs, and difficulties in repeating the procedure multiple times. An alternative approach, liquid biopsy, analyzes genetic mutations in body fluids like blood. This method is simpler, repeatable, and can overcome the prob ...View more

A personalized liquid biopsy platform is available for early monitoring of cancer recurrence after surgery. This platform detects tumor specific genetic mutations in cancer tissues during surgery, creates personalized gene panels, and performs minimal residual disease (MRD) monitoring after surgery.The test results can guide adjustments in anticancer drug and treatment p ...View more